Business Archives - Page 44 of 47

Rockville’s Quantum Space Announces Plans for Robotic Outpost on the Moon

Published February 8, 2022 at 4:08PM

Quantum Space was founded in 2021 in Rockville by a trio of space industry veterans, Kam Ghaffarian, Steve Jurczyk, and Ben Reed. With emphasis on rapid technological advancement while lowering the cost to access cis-lunar space, the company is focused on enabling a future where innovation and sustainability meet propelling human progress, economic growth and expanding space access, and its vast ability to improve life on Earth.

Last week, Quantum Space announced place for a space venture focused on developing the first commercial lunar robotic outpost

Stretch Zone Opens First Maryland Location in MoCo

By MCS Staff

Published February 6, 2022 at 8:39PM

Stretch Zone, the nation’s first and largest practitioner-assisted stretching company, continues expanding throughout the United States with its first Maryland location now open in the Kentlands neighborhood of Gaithersburg. Stretch Zone takes over the former GNC location at 251 Kentlands Blvd, the former home of GNC.

Stretch Zone, the company that brought practitioner-assisted stretching to the public and introduced a new vertical in the health and wellness industry, closed out 2021 with a record-breaking year of milestones, from its fastest growth of studio openings to its highest-revenue year.

Bethesda’s Phillips Realty Capital Acquired

By MCS Staff

Published February 5, 2022 at 10:02AM | Updated February 5, 2022 at 7:03PM

Bellwether Enterprise Real Estate Capital LLC (BWE), the commercial and multifamily mortgage banking subsidiary of Enterprise Community Investment Inc. (Enterprise), announced in January that it acquired Bethesda-based, Phillips Realty Capital (Phillips).

Based in Bethesda, with offices in Alexandria, Charlottesville and Richmond, VA, Phillips has been a fixture in the Washington, D.C. real estate community for 85 years. Led by C. Stephen Shaw, Jr., now executive vice president, the team of experienced commercial real estate finance professionals will now be part of a national, privately-owned platform that will provide expanded financing solutions for its clients.

Beyond MoCo: LEGO Discovery Center is Coming to Springfield Town Center in Fairfax County

By MCS Staff

Published February 5, 2022 at 9:41AM | Updated March 22, 2023 at 6:48PM

PREIT, a real estate investment trust, announced that nearby Springfield Town Center has executed an agreement with Merlin Entertainments, the world’s second-largest visitor attractions operator, to launch the next generation of LEGO(R) Discovery Center in 2023. The 32,000 square foot indoor attraction has been co-created by Merlin & the LEGO Group and will be accessible on one level right off the main entrance to the property. Springfield Town Center is in Springfield, Virginia in Fairfax County, at the intersection of I-95, 395, 495, and Fairfax Parkway. There are currently 14 Legoland Discovery Centers in the United States and 13 overseas, with the closest being in Philadelphia.

“We are delighted to be opening an indoor LEGO attraction in Washington DC at Springfield Town Center. Our LEGO themed attractions have been a huge success across the globe, providing an opportunity for adults and children to spend fun and quality time together in an awesome LEGO world. We look forward to revealing more special details over the coming months ahead of welcoming our first visitors in 2023,” said Meike Lippert, Senior Divisional Director Midway Europe and Global New Openings, Merlin Entertainments. “This new attraction helps PREIT achieve its goal of creating high quality purposeful places that serve as one-stop destinations for customers at a key property in a growing market,” said Joseph F. Coradino, Chairman and CEO of PREIT. “Experiential tenants have proven to be great catalysts throughout our portfolio and we expect that, upon opening, our trade area will expand by a two hour drive time, driving traffic and sales.”

Bark Social ‘Dog Bar’ Raises Additional $2 Million in Funding For East Coast Expansion

By MCS Staff

Published February 4, 2022 at 10:40AM

It has been just under a year since Bark Social opened its gates in Pike & Rose, adjacent to Rose Park and next to Julii and Jinya. BizJournals reports that the “social club for dogs and their owners has raised another $2 million to fuel its growth in Greater Washington and other metro areas along the East Coast.” Per the report, it’s the latest of three funding rounds for the company, for a total of around $5.3 million. Bark Social will start with a new location in Baltimore (Canton) and plan on at least two more locations in D.C. and Philadelphia to be announced soon.

The existing venue consists of a 25,000 square foot dog park plus a 2,500 square foot climate controlled clubhouse as well as a bar/cafe and gift shop. The dog park is off-leash and monitored by trained professionals at all times and there is a separate area for small dogs as well.

Tower Installs Largest Solar Canopy in City of Rockville

By MCS Staff

Published February 2, 2022 at 4:36PM

New solar PV system will generate 20% of the office building’s electricity needs each year

Yesterday, The Tower Companies and Prospect Solar, LLC announced that The Tower Building, located at 1101 Wootton Parkway in Rockville, flipped the switch on Tower’s largest on-site solar photovoltaic (PV) system. The project is also the largest solar PV Canopy installation in the City of Rockville and will contribute to Maryland’s long-term goal of net-zero GHG emissions by 2045.

MoCo-Based Lockheed Martin Awarded $1.42 Billion Contract

By MCS Staff

Published February 1, 2022 at 10:22AM | Updated February 1, 2022 at 9:28PM

The United States Department of Defense announced the contract awarded to Bethesda’s Lockheed Martin

Lockheed Martin, which is headquartered in Montgomery County, has been awarded a $1,420,000,000 indefinite-delivery/indefinite-quantity contract for the C-130J mission sustainment support effort.

MoCo-Based Lockheed Martin Reports Fourth Quarter And Full Year 2021 Financial Results

By MCS Staff

Published February 1, 2022 at 9:37AM

– Net sales of $17.7 billion in the fourth quarter and $67.0 billion in 2021

– Net earnings from continuing operations of $2.0 billion, or $7.47 per share, in the fourth quarter and $6.3 billion, or $22.76 per share, in 2021

Gaithersburg-Based Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine

By MCS Staff

Published January 31, 2022 at 4:34PM

Per Novavax:

GAITHERSBURG, Md., Jan. 31, 2022 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that it has submitted a request to the U.S Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) for NVX-CoV2373, its protein-based COVID-19 vaccine candidate for immunization of individuals 18 year of age and older against SARS-CoV-2.

Gaithersburg’s Novavax and Israel Announce Advance Purchase Agreement for Supply of COVID-19 Vaccine

By MCS Staff

Published January 29, 2022 at 12:27PM

The Novavax vaccine would be the first protein-based alternative available in Israel

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company based in Gaithersburg dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Israel’s Ministry of Health today announced an agreement for the purchase of NVX-CoV2373, the company’s recombinant nanoparticle protein-based COVID-19 vaccine candidate with Matrix-M™ adjuvant.

Rockville’s Immunocore Announced FDA Approval of KIMMTRAK For Treatment of Uveal Melanoma

By MCS Staff

Published January 27, 2022 at 6:02PM | Updated January 28, 2022 at 2:08PM

Immunocore is a commercial-stage biotechnology company based in England with its U.S. headquarters in Rockville, pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease – designed to treat a broad range of diseases, including cancer, autoimmune, and infectious disease.

Yesterday, Immunocore announced the FDA approval of KIMMTRAK for the treatment of unresectable or metastatic uveal melanoma. Uveal melanoma is a rare and aggressive form of melanoma, which affects the eye. Although it is the most common primary intraocular malignancy in adults, the diagnosis is rare, and up to 50% of people with uveal melanoma will eventually develop metastatic disease. Unresectable or metastatic uveal melanoma typically has a poor prognosis and had no approved treatment until KIMMTRAK.